Related Experiment Video
Updated: Mar 19, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in
Jonas K Eriksson1, Lennart Jacobsson2, Karin Bengtsson2
1Clinical Epidemiology Unit and Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Insights
Patients with ankylosing spondylitis (AS) face a 30%-50% higher risk of cardiovascular events compared to the general population. This risk is similar for stroke but lower for acute coronary syndromes and thrombotic events than in rheumatoid arthritis (RA).
Area of Science:
- Rheumatology
- Cardiology
- Epidemiology
Background:
- Ankylosing spondylitis (AS) and rheumatoid arthritis (RA) are chronic inflammatory conditions.
- Cardiovascular (CV) disease is a significant concern in patients with inflammatory arthropathies.
- Understanding CV risk phenotypes in AS and RA is crucial for patient management.
Purpose of the Study:
- To compare the incidence of cardiovascular events between patients with AS, RA, and the general population.
- To analyze CV event risk by specific phenotypes (acute coronary syndromes, thromboembolic events, stroke).
Main Methods:
- Utilized national registries to identify cohorts of AS (n=5358), RA (n=37,245), and matched general population subjects (n=25,006).
- Followed cohorts from 2006-2011 until December 31, 2012, for incident CV events.
- Calculated age/sex-standardized incidence rates and relative risks using Cox proportional hazards models.
Main Results:
- Patients with AS showed a 1.3-fold increased risk for acute coronary syndromes (ACS) and a 1.4-fold increased risk for thromboembolic events compared to the general population.
- Patients with RA had a 1.7-fold increased risk for ACS and a 1.8-fold increased risk for thromboembolic events.
- Both AS and RA patients exhibited a 1.5-fold increased risk for stroke compared to the general population.
Conclusions:
- Prevalent AS patients have a 30%-50% increased risk of incident CV events.
- Compared to RA patients, AS patients had a similar risk increase for stroke but a lower risk for ACS and thrombotic events.
Aims:
To assess and compare the incidence of cardiovascular (CV) events, by CV phenotype, between patients with ankylosing spondylitis (AS), rheumatoid arthritis (RA) and the general population.
Methods:
Using linkages of national and population-based registers, we identified one cohort of prevalent patients with AS (n=5358), one with RA (n=37 245) and one with matched general population subjects (n=25 006). These cohorts were identified in 2006 through 2011 and were followed in 31 December 2012, for first ever occurrence of acute coronary syndromes (ACS), deep venous thromboembolism, pulmonary embolism and stroke, respectively. For each outcome, we calculated incidence rates standardised to the age and sex distribution of the AS cohort, as well as relative risks using Cox proportional hazards models.
Results:
Based on 69 ACS events during 20 251 person-years of follow-up of the patients with AS, and 966 events during 127 014 person-years in the RA cohort, the age/sex-adjusted relative risks for ACS compared with the general population was 1.3 (95% CI 1.0 to 1.7) for AS and 1.7 (1.4 to 2.0) for RA. For thromboembolic events, the corresponding risks were 1.4 (1.1 to 1.9) in AS and 1.8 (1.5 to 2.1) in RA. Finally, for stroke, the relative risks were 1.5 (1.1 to 2.0) in AS and 1.5 (1.2 to 1.8) in RA, compared with the general population.
Conclusions:
Prevalent patients with AS are at a 30%-50% increased risk of incident CV events. When compared with patients with RA, this level of increase was similar for stroke, but only half as high for ACS and thrombotic events.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease IV: Preventive Measures
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

